Dashboard
1
With a growth in Net Sales of 26.2%, the company declared Very Positive results in Sep 25
- OPERATING CASH FLOW(Y) Highest at CNY 338.72 MM
- CASH AND EQV(HY) Highest at CNY 1,016.64 MM
- DEBT-EQUITY RATIO (HY) Lowest at -25.64 %
2
With ROE of 12.81%, it has a very expensive valuation with a 8.62 Price to Book Value
3
Below par performance in long term as well as near term
Stock DNA
Pharmaceuticals & Biotechnology
CNY 4,708 Million (Mid Cap)
67.00
NA
0.00%
-0.32
12.56%
5.55
Revenue and Profits:
Net Sales:
353 Million
(Quarterly Results - Mar 2026)
Net Profit:
41 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-14.4%
0%
-14.4%
6 Months
-15.33%
0%
-15.33%
1 Year
-41.3%
0%
-41.3%
2 Years
60.91%
0%
60.91%
3 Years
6.67%
0%
6.67%
4 Years
19.56%
0%
19.56%
5 Years
31.95%
0%
31.95%
Doctorglasses Chain Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
17.40%
EBIT Growth (5y)
22.13%
EBIT to Interest (avg)
17.52
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.26
Sales to Capital Employed (avg)
1.29
Tax Ratio
21.29%
Dividend Payout Ratio
45.68%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
21.66%
ROE (avg)
13.77%
Valuation key factors
Factor
Value
P/E Ratio
67
Industry P/E
Price to Book Value
8.62
EV to EBIT
53.39
EV to EBITDA
23.52
EV to Capital Employed
15.80
EV to Sales
5.17
PEG Ratio
NA
Dividend Yield
0.51%
ROCE (Latest)
29.60%
ROE (Latest)
12.81%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
353.20
279.90
26.19%
Operating Profit (PBDIT) excl Other Income
47.60
95.20
-50.00%
Interest
1.90
0.60
216.67%
Exceptional Items
5.10
20.00
-74.50%
Consolidate Net Profit
41.40
62.10
-33.33%
Operating Profit Margin (Excl OI)
134.70%
208.10%
-7.34%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 26.19% vs -28.98% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is -33.33% vs 87.05% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,355.40
1,199.40
13.01%
Operating Profit (PBDIT) excl Other Income
327.80
294.80
11.19%
Interest
12.00
12.80
-6.25%
Exceptional Items
15.00
-13.30
212.78%
Consolidate Net Profit
153.70
101.30
51.73%
Operating Profit Margin (Excl OI)
131.10%
111.90%
1.92%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 13.01% vs 2.37% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 51.73% vs -23.14% in Dec 2024
About Doctorglasses Chain Co., Ltd. 
Doctorglasses Chain Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






